Meyer Andrew Hollman (CIK 1864159) reported 21 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-02). Recent activity: Sell JANX (1,879 shares), Buy JANX (3,333 shares), Sell JANX (2,700 shares), Sell JANX (633 shares), Buy JANX (3,333 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-02 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Sell | 1,879 | $25,799 |
| 2025-12-03 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Buy | 3,333 | $35,296 |
| 2025-12-03 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Sell | 2,700 | $88,695 |
| 2025-12-03 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Sell | 633 | $21,218 |
| 2025-11-14 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Buy | 3,333 | $35,296 |
| 2025-11-14 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Sell | 3,333 | $99,990 |
| 2025-10-30 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Buy | 9,999 | $42,096 |
| 2025-10-30 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Buy | 6,666 | $70,593 |
| 2025-10-30 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Sell | 16,665 | $500,950 |
| 2025-05-02 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Buy | 3,333 | $14,032 |
| 2025-05-02 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Sell | 2,933 | $93,709 |
| 2025-05-02 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Sell | 400 | $13,040 |
| 2025-04-23 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Buy | 3,334 | $14,036 |
| 2025-04-23 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Sell | 3,334 | $100,020 |
| 2025-03-05 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Buy | 3,334 | $14,036 |
| 2025-03-05 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Sell | 2,433 | $77,564 |
| 2025-03-05 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Sell | 901 | $29,598 |
| 2025-02-05 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Buy | 3,334 | $14,036 |
| 2025-02-05 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Sell | 2,418 | $101,749 |
| 2025-02-05 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Sell | 816 | $34,900 |
| 2025-02-05 | Janux Therapeutics, Inc. (JANX) | Chief Business Officer | Sell | 100 | $4,360 |
Source: SEC Form 4 filings · as of 2026-01-02